The Medical Journal of Australia
Episode 523: MJA Podcasts 2023 Episode 17: Clinical practice guidelines for deprescribing opioids, with Aili Langford and Associate Professor Carl Schneider
Jul 30, 2023
Aili Langford and Associate Professor Carl Schneider discuss clinical practice guidelines for deprescribing opioids, focusing on developing flexible approaches, individualizing plans, monitoring, and co-interventions. They explore Australia's high opioid prescribing rates, adverse effects, rising deaths, and the importance of tailored deprescribing strategies.
12:52
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Clinical practice guidelines address unintended consequences of opioid use like suicide and overdose.
- Recommendations focus on tailoring deprescribing plans to individual needs with gradual tapering.
Deep dives
Need for Deep Describing Opioids Guidelines
The podcast discusses the development of the first clinical practice guidelines for deep describing opioids in response to the unintended consequences of the 2016 CDC guideline in the United States. The need for these guidelines arose due to issues such as inflexible application of dose ceilings and abrupt cessation of opioids leading to increased rates of suicide and overdose. These guidelines focus on situations where it is essential to deep describe opioids and provide recommendations to limit opioid dose and duration, particularly for acute pain conditions.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
